It looks like nothing was found at this location. Maybe try one of the links below or a search?
Popular Articles:
-
Response to EPO consultation: Don’t impose oral proceedings by videoconference
-
Quality at the EPO – One Modest and one Serious Proposal
-
‘Opposition against Unitary Patent comes from fearful lawyers and critics who only have a theoretical interest’
-
Leading German patent law firms criticize European Patent Office
-
UPC: four reasons on why the PPA is not legally in force
-
The EPO’s Vision (V) – Trust
Recent Articles:
-
Announcement of the national program “MOVER” raises expectations for an increase in patent filings for green technology
-
UPC “saisie-contrefaçon” Part III: the “C-Kore” case
-
Brazil: Animal Health and Patent Litigation
-
China’s Supreme People Court decides FRAND dispute in ACT v Oppo
-
UPC “saisie-contrefaçon” Part II: the “OERLIKON” case
-
UPC “saisie-contrefaçon” Part I: the texts
Random Articles:
-
Russia: New remedy against an infringing generic drug
-
‘Successor EPO president Benoît Battistelli to be chosen this autumn’
-
Merck vs. Ratiopharm, Court of Appeal Helsinki (Helsingin Hovioikeus), 31 December 2010
-
Book Review: Overview of the Appeal Proceedings according to the EPC, Third Edition
-
CJEU’s Advocate General in Abraxis (C-443/17) denies SPCs for new formulations of old drugs and questions Neurim approach
-
Olanzapin, District Court The Hague (Rechtbank Den Haag), 24 March 2010
-
Düsseldorf Higher Regional Court confirms case law on the issuance of preliminary injunctions against generic companies
-
Decision in Spanish challenge of Unitary Patent Package on 5 May 2015
-
UK will ratify UPCA in March and has political will to stay in Unitary Patent system post-Brexit
-
Patent case: In re Juniper Networks Inc., USA